Localization and Expression of Tissue Kallikrein and Kallistatin in Human Blood Vessels
Open Access
- 1 February 1999
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 47 (2) , 221-228
- https://doi.org/10.1177/002215549904700210
Abstract
Tissue kallikrein releases kinins by specific proteolysis, an activity inhibited by kallistatin. In this study, kallikrein and kallistatin were localized to endothelial and smooth muscle cells of large, medium, and small normal blood vessels by immunohistochemical techniques. Immunostaining for both proteins was strong in the endothelium of all sizes of blood vessels and was more intense in medial smooth muscle cells of small and medium-sized blood vessels than in elastic arteries. The sites of synthesis by endothelial and smooth muscle cells were demonstrated in normal blood vessels of all sizes by in situ hybridization histochemistry. Kallikrein and kallistatin levels were measured by immunoassays in homogenates of human aorta, vena cava, and iliac artery and vein. Tissue kallikrein and kallistatin transcripts were identified in human blood vessels by RT-PCR followed by Southern blot analysis with specific oligonucleotide probes. The results demonstrated the expression and co-localization of tissue kallikrein and kallistatin in human vessels and suggest a potential role of kallistatin in regulating tissue kallikrein in blood vessels.Keywords
This publication has 28 references indexed in Scilit:
- Regulation of mitogenesis by kinins in arterial smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 1997
- Kallistatin is a potent new vasodilator.Journal of Clinical Investigation, 1997
- Beneficial effects of Kallikrein-binding protein in transgenic mice during endotoxic shockLife Sciences, 1997
- Adenovirus-Mediated Delivery of Human Kallistatin Gene Reduces Blood Pressure of Spontaneously Hypertensive RatsHuman Gene Therapy, 1997
- Kallistatin, a novel human tissue kallikrein inhibitor: Levels in body fluids, blood cells, and tissues in health and diseaseJournal of Laboratory and Clinical Medicine, 1996
- Role of Endogenous Bradykinin in Human Coronary Vasomotor ControlCirculation, 1995
- Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidneyKidney International, 1995
- Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharidesBlood Coagulation & Fibrinolysis, 1995
- Inhibition of bradykinin‐induced vasodilation in human forearm vasculature by icatibant, a potent B2‐receptor antagonist.British Journal of Clinical Pharmacology, 1994
- Identification of a tissue kallikrein in human polymorphonuclear leucocytesBritish Journal of Haematology, 1989